|
ATXN1L expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.196450E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.556800E-04 |
| Normal-vs-Stage2 |
3.207700E-02 |
| Normal-vs-Stage3 |
1.266810E-01 |
| Normal-vs-Stage4 |
4.01469999999904E-05 |
| Stage1-vs-Stage2 |
7.968200E-01 |
| Stage1-vs-Stage3 |
5.221800E-01 |
| Stage1-vs-Stage4 |
1.185530E-02 |
| Stage2-vs-Stage3 |
8.043800E-01 |
| Stage2-vs-Stage4 |
5.822400E-02 |
| Stage3-vs-Stage4 |
2.411500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.319300E-03 |
| Normal-vs-AfricanAmerican |
6.004100E-04 |
| Normal-vs-Asian |
4.607000E-01 |
| Caucasian-vs-AfricanAmerican |
1.861430E-01 |
| Caucasian-vs-Asian |
9.401400E-01 |
| AfricanAmerican-vs-Asian |
8.227400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.446800E-04 |
| Normal-vs-Female |
5.822100E-02 |
| Male-vs-Female |
2.343400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.647530E-04 |
| Normal-vs-Extreme_Weight |
1.152900E-04 |
| Normal-vs-Obese |
5.918000E-02 |
| Normal-vs-Extreme_Obese |
2.917800E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.048400E-01 |
| Normal_Weight-vs-Obese |
2.870000E-02 |
| Normal_Weight-vs-Extreme_Obese |
5.130400E-01 |
| Extreme_Weight-vs-Obese |
1.821690E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.929800E-01 |
| Obese-vs-Extreme_Obese |
4.934400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.328170E-02 |
| Normal-vs-Age(41-60Yrs) |
2.775900E-02 |
| Normal-vs-Age(61-80Yrs) |
2.767000E-04 |
| Normal-vs-Age(81-100Yrs) |
1.436020E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.943200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.652400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.448800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.140420E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.543600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.051000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.218800E-03 |
| Normal-VS-Type2 PRCC |
2.878400E-03 |
| Normal-VS-KIRP CIMP |
4.235600E-03 |
| Normal-VS-Unclassified PRCC |
9.689800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.976600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.443000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.340100E-02 |
| Type2 PRCC-VS-KIRP CIMP |
5.230000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.671800E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.233600E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.944900E-03 |
| Normal-vs-N1 |
5.182600E-03 |
| Normal-vs-N2 |
2.144700E-03 |
| N0-vs-N1 |
9.842400E-01 |
| N0-vs-N2 |
1.263540E-02 |
| N1-vs-N2 |
1.590570E-01 |
|
|
